CSIMarket
 


Boston Scientific Corporation  (BSX)
Other Ticker:  
 
 

BSX's Free Cash Flow Growth by Quarter and Year

Boston Scientific's Free Cash Flow results by quarter and year




BSX Free Cash Flow (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 673.00 692.00 501.00
III Quarter September - 643.00 502.00 -403.00
II Quarter June - 269.00 332.00 193.00
I Quarter March 284.00 -77.00 19.00 872.00
FY   284.00 1,508.00 1,545.00 1,163.00



BSX Free Cash Flow first quarter 2021 Y/Y Growth Comment
Boston Scientific Corporation in the first quarter achieved Free Cash Flow of $ 284.00 millions compare to free cash outflow recorded in same quarter a year ago.

Looking into first quarter results within Medical Equipment & Supplies industry 11 other companies have achieved higher Free Cash Flow growth. While Boston Scientific Corporation' s Free Cash Flow no change of % ranks overall at the positon no. 428 in the first quarter.




BSX Free Cash Flow ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - -2.75 % 38.12 % 96.47 %
III Quarter September - 28.09 % - -
II Quarter June - -18.98 % 72.02 % 69.3 %
I Quarter March - - -97.82 % 100.46 %
FY   - -2.39 % 32.85 % 17.59 %

Financial Statements
Boston Scientific's first quarter 2021 Free Cash Flow $ 284.00 millions BSX's Income Statement
Boston Scientific's first quarter 2020 Free Cash Flow $ -77.00 millions Quarterly BSX's Income Statement
New: More BSX's historic Free Cash Flow Growth >>


BSX Free Cash Flow (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 4.67 % 37.85 % -
III Quarter September - 139.03 % 51.2 % -
II Quarter June - - 1647.37 % -77.87 %
I Quarter March -57.8 % - -96.21 % 241.96 %
FY (Year on Year)   - -2.39 % 32.85 % 17.59 %




Free Cash Flow first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #12
Healthcare Sector #46
Overall #428

Free Cash Flow Y/Y Growth Statistics
High Average Low
175.32 % 5.17 % -56.89 %
(Sep 30 2019)   (Dec 31 2018)
Free Cash Flow first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #12
Healthcare Sector #46
Overall #428
Free Cash Flow Y/Y Growth Statistics
High Average Low
175.32 % 5.17 % -56.89 %
(Sep 30 2019)   (Dec 31 2018)

Free Cash Flow by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Boston Scientific's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
4884.21 % 138.66 % -96.21 %
(Mar 31 2019)  


BSX's I. Quarter Q/Q Free Cash Flow Comment
In the I. Quarter 2021 Boston Scientific Corporation reported fall in Free Cash Flow from the forth quarter by -57.8% to $ 284.00 millions, from $ 673.00 millions released a quarter before.

Within Medical Equipment & Supplies industry 22 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Boston Scientific's Free Cash Flow growth quarter on quarter, overall rank is 1079.


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #23
Healthcare Sector #88
Overall #1079
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #23
Healthcare Sector #88
Overall #1079
Free Cash Flow Q/Q Growth Statistics
High Average Low
4884.21 % 138.66 % -96.21 %
(Mar 31 2019)  


BSX's I. Quarter Q/Q Free Cash Flow Comment
In the I. Quarter 2021 Boston Scientific Corporation realized fall in Free Cash Flow from the forth quarter by -57.8% to $ 284.00 millions, from $ 673.00 millions achived in the previous reporting period.

Within Medical Equipment & Supplies industry 22 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Boston Scientific's Free Cash Flow growth quarter on quarter, overall rank is 1079.


Boston Scientific's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Free Cash Flow 12 Months Ending $ 2,220.00 $ 1,884.00 $ 1,930.00 $ 1,861.00 $ 1,249.00
Y / Y Free Cash Flow Growth (TTM) 77.74 % 12.75 % 110.24 % 113.42 % 52.69 %
Year on Year Free Cash Flow Growth Overall Ranking # 274 # 1114 # 333 # 241 # 372
Seqeuential Free Cash Flow Change (TTM) 17.83 % -2.38 % 3.71 % 49 % -25.25 %
Seq. Free Cash Flow Growth (TTM) Overall Ranking # 428 # 1529 # 1145 # 217 # 1946




Cumulative Free Cash Flow growth Comment
Boston Scientific saw improvement in Free Cash Flow growth trend, posting cumulative 12 months Free Cash Flow growth of 77.74% year on year, to $ 2,220 millions if the fiscal year would have ended in Mar 31 2021.
Boston Scientific's trailing twelve months Free Cash Flow growth was higher than company's average 15.25% and higher than 12.75% growth in Dec 31 2020.
But from twelve months ended Dec 31 2020 rise was less at 17.83 % from $1884 millions reported in twelve months ending a quarter before.
Yet this was evidence of strength, as the usual Q/Q TTM Free Cash Flow gain lays at 5.17%.
The progress was much higher from the previous reporting period showed at 17.83 % increase from $1884 millions in the period from Dec 31 2020 to Mar 31 2020.

Within the Healthcare sector 34 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 274, from total ranking in previous quarter at 1114.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
175.32 %
5.17 %
-56.89 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 12
Healthcare Sector # 35
Overall # 274

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
203.53 %
15.25 %
-78.33 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 46
S&P 500 # 428
Cumulative Free Cash Flow growth Comment
Boston Scientific saw improvement in Free Cash Flow growth trend, posting cumulative 12 months Free Cash Flow growth of 77.74% year on year, to $ 2,220 millions if the fiscal year would have ended in Mar 31 2021.
Boston Scientific's trailing twelve months Free Cash Flow growth was higher than company's average 15.25% and higher than 12.75% growth in Dec 31 2020.
But from twelve months ended Dec 31 2020 increase was less at 17.83 % from $1884 millions reported in twelve months ending a quarter before Navya Pawar added on.
In spite of, it was evidence of positive momentum, as the usual sequential Free Cash Flow advancement is at 5.17%.
The growth is even more impressive sequentially exhibited at 17.83 % increase from $1884 millions in twelve months ending a quarter before.

Within the Healthcare sector 34 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 274, from total ranking in previous quarter at 1114.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
175.32 %
5.17 %
-56.89 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 12
Healthcare Sector # 35
Overall # 274

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
203.53 %
15.25 %
-78.33 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 46
S&P 500 # 428




Other Free Cash Flow Growth
Medical Equipment & Supplies Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
BSX's Free Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for BSX's Competitors
Free Cash Flow Growth for Boston Scientific's Suppliers
Free Cash Flow Growth for BSX's Customers

You may also want to know
BSX's Annual Growth Rates BSX's Profitability Ratios BSX's Asset Turnover Ratio BSX's Dividend Growth
BSX's Roe BSX's Valuation Ratios BSX's Financial Strength Ratios BSX's Dividend Payout Ratio
BSX's Roa BSX's Inventory Turnover Ratio BSX's Growth Rates BSX's Dividend Comparisons



Companies with similar Free Cash Flow fall for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Mar 31 2021
Option Care Health Inc -0.12%$ -0.125 millions
Amgen Inc -1.41%$ -1.406 millions
Bristol Myers Squibb Co-1.80%$ -1.798 millions
Zoetis Inc -1.96%$ -1.961 millions
Utah Medical Products Inc-2.49%$ -2.485 millions
Repligen Corp-2.81%$ -2.812 millions
Regeneron Pharmaceuticals Inc -4.23%$ -4.226 millions
Lifevantage Corp-4.76%$ -4.763 millions
Electromed Inc -6.16%$ -6.160 millions
Resmed Inc -18.11%$ -18.113 millions
Iradimed Corp-21.19%$ -21.189 millions
Stryker Corp-23.52%$ -23.519 millions
Corcept Therapeutics Inc-23.59%$ -23.587 millions
Adapthealth Corp -24.61%$ -24.611 millions
Henry Schein Inc -30.00%$ -30.002 millions
Radnet Inc -31.36%$ -31.357 millions
Ligand Pharmaceuticals Incorporated-36.45%$ -36.450 millions
Diversified Healthcare Trust-38.16%$ -38.162 millions
Phibro Animal Health Corp-38.31%$ -38.312 millions
Catalent Inc -38.37%$ -38.373 millions
Atrion Corporation-42.30%$ -42.296 millions
Zimmer Biomet Holdings Inc -45.33%$ -45.332 millions
Catalyst Pharmaceuticals Inc -47.12%$ -47.124 millions
Biogen Inc -47.59%$ -47.591 millions
Avantor Inc -49.86%$ -49.862 millions
Tivity Health Inc -51.90%$ -51.900 millions
Davita Inc -57.18%$ -57.183 millions
United Therapeutics Corporation-58.15%$ -58.155 millions
Harvard Bioscience Inc-63.88%$ -63.880 millions
Antares Pharma Inc -64.55%$ -64.552 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CTGO's Profile

Stock Price

CTGO's Financials

Business Description

Fundamentals

Charts & Quotes

CTGO's News

Suppliers

CTGO's Competitors

Customers & Markets

Economic Indicators

CTGO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071